Oligonucleotide Synthesis Market by Product (Probe, Linkers, Adaptor, Drugs, Reagent, Equipment), Type (Custom, Pre Design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Hospital, Pharmaceutical, Biotechnology) - Global Forecast to 2024

Abstract
Apex Market Research has published a new report titled ”Global Oligonucleotide Synthesis Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Oligonucleotide Synthesis market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the Oligonucleotide Synthesis market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global Oligonucleotide Synthesis market report offers in-depth insights, revenue details, and other vital information regarding the global Oligonucleotide Synthesis market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of Oligonucleotide Synthesis market. The major players operating into Oligonucleotide Synthesis Market include: IDT (US)
Sigma-Aldrich Corporation (US)
Eurogentec (Belgium)
Eurofins Genomics (Germany)
Agilent Technologies (US)
Thermo Fisher Scientific (US) BioAutomation (US)
LGC Biosearch Technologies (US)
GeneDesign (Japan)
GE Healthcare (US)
TriLink BioTechnologies (US)
GenScript (China)
Nitto Denko Avecia (US)
ATDBio (UK)
Bio-Synthesis (US)
IBA GmbH (Germany)
Gene Link (US)
and AITbiotech Pte. (Singapore) Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value Value (USD)
Covered Segments Products & type, applications, end users, and regions
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the Oligonucleotide Synthesis market to forecast revenues and analyze trends in each of the following submarkets:

Oligonucleotide Synthesis Market, by Product & Type

  • Synthesized Oligonucleotides
    • By Product
      • Oligonucleotide-based Drugs
      • Primers
      • Probes
      • Large-scale Synthesized Oligonucleotides
      • Intermediate-scale Synthesized Oligonucleotides
      • Linkers & Adaptors
    • By Type
      • Custom Oligonucleotides
      • Pre-designed Oligonucleotides
  • Reagents
  • Equipment

Oligonucleotide Synthesis Market, by Application

  • Research
    • PCR
    • QPCR
    • Sequencing
    • Gene Synthesis
    • Other Research Applications (nucleic acid hybridization methods and isothermal amplification methods)
  • Diagnostics
  • Therapeutics 
    • DNA & Antisense Oligonucleotide-based Therapies
    • RNAi Oligonucleotide-based Therapies
    • CpG Oligonucleotide-based Therapies

Oligonucleotide Synthesis Market, by End User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Hospitals
By geography, this market has been segregated into five regions with revenue and growth rate of Oligonucleotide Synthesis from 2020 to 2027,
There are 13 chapters to put on view for Oligonucleotide Synthesis Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Oligonucleotide Synthesis Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Oligonucleotide Synthesis Market Overview 1.1.1 Oligonucleotide Synthesis Product Scope 1.1.2 Market Status and Outlook 1.2 Global Oligonucleotide Synthesis Market Size and Analysis by Regions (2015-2019) 1.2.1 North America Oligonucleotide Synthesis Market Status and Outlook 1.2.2 EU Oligonucleotide Synthesis Market Status and Outlook 1.2.3 Japan Oligonucleotide Synthesis Market Status and Outlook 1.2.4 China Oligonucleotide Synthesis Market Status and Outlook 1.2.5 India Oligonucleotide Synthesis Market Status and Outlook 1.2.6 Southeast Asia Oligonucleotide Synthesis Market Status and Outlook 1.3 Global Oligonucleotide Synthesis Market Segment Oligonucleotide Synthesis Market, by Product & Type
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.2 Synthesized Oligonucleotides
1.3.3 By Product
1.3.3.1 Oligonucleotide-based Drugs
1.3.3.2 Primers
1.3.3.3 Probes
1.3.3.4 Large-scale Synthesized Oligonucleotides
1.3.3.5 Intermediate-scale Synthesized Oligonucleotides
1.3.3.6 Linkers & Adaptors
1.3.3.7 Market Estimates And Forecast By Country, 2015-2027
1.3.4 By Type
1.3.4.1 Custom Oligonucleotides
1.3.4.2 Pre-designed Oligonucleotides
1.3.4.3 Market Estimates And Forecast By Country, 2015-2027
1.3.4.2 Reagents
1.3.4.3 Market Estimates And Forecast By Country, 2015-2027
1.3.4.2 Equipment
1.3.4.3 Market Estimates And Forecast By Country, 2015-2027
1.4 Global Oligonucleotide Synthesis Market Segment Oligonucleotide Synthesis Market, by Application
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.2 Research
1.4.2.1 PCR
1.4.2.2 QPCR
1.4.2.3 Sequencing
1.4.2.4 Gene Synthesis
1.4.2.5 Other Research Applications (nucleic acid hybridization methods and isothermal amplification methods)
1.4.2.6 Market Estimates And Forecast By Country, 2015-2027
1.4.2.5 Diagnostics
1.4.2.6 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Therapeutics 
1.4.3.1 DNA & Antisense Oligonucleotide-based Therapies
1.4.3.2 RNAi Oligonucleotide-based Therapies
1.4.3.3 CpG Oligonucleotide-based Therapies
1.4.3.4 Market Estimates And Forecast By Country, 2015-2027
1.5 Global Oligonucleotide Synthesis Market Segment Oligonucleotide Synthesis Market, by End User
1.5.1 Introduction
1.5.1.1 Market Estimates And Forecast 2015-2027
1.5.1 Academic & Research Institutes
1.5.1.1 Market Estimates And Forecast By Country, 2015-2027
1.5.2 Pharmaceutical & Biotechnology Companies
1.5.2.1 Market Estimates And Forecast By Country, 2015-2027
1.5.3 Diagnostic Laboratories
1.5.3.1 Market Estimates And Forecast By Country, 2015-2027
1.5.4 Hospitals
1.5.4.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global Oligonucleotide Synthesis Competition Analysis by Players 2.1 Global Oligonucleotide Synthesis Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 IDT (US) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 IDT (US), Oligonucleotide Synthesis Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Sigma-Aldrich Corporation (US) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Sigma-Aldrich Corporation (US), Oligonucleotide Synthesis Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 Eurogentec (Belgium) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Eurogentec (Belgium), Oligonucleotide Synthesis Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 Eurofins Genomics (Germany) 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Eurofins Genomics (Germany), Oligonucleotide Synthesis Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 Agilent Technologies (US) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Agilent Technologies (US), Oligonucleotide Synthesis Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 Thermo Fisher Scientific (US) BioAutomation (US) 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Thermo Fisher Scientific (US) BioAutomation (US), Oligonucleotide Synthesis Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 LGC Biosearch Technologies (US) 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 LGC Biosearch Technologies (US), Oligonucleotide Synthesis Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 GeneDesign (Japan) 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 GeneDesign (Japan), Oligonucleotide Synthesis Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 GE Healthcare (US) 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 GE Healthcare (US), Oligonucleotide Synthesis Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 TriLink BioTechnologies (US) 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 TriLink BioTechnologies (US), Oligonucleotide Synthesis Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global Oligonucleotide Synthesis Market Size Type (2015-2019) 4.1 Global Oligonucleotide Synthesis Market Size by Type (2015-2019) Chapter 5 Global Oligonucleotide Synthesis Market Size Application (2015-2019) 5.1 Global Oligonucleotide Synthesis Market Size by Application (2015-2019) 5.2 Potential Application of Oligonucleotide Synthesis in Future 5.3 Top Consumer / End Users of Oligonucleotide Synthesis Chapter 6 North America Oligonucleotide Synthesis Development Status and Outlook 6.1 North America Oligonucleotide Synthesis Market Size (2015-2019) 6.2 North America Oligonucleotide Synthesis Market Size by Application (2015-2019) Chapter 7 EU Oligonucleotide Synthesis Development Status and Outlook 7.1 EU Oligonucleotide Synthesis Market Size (2015-2019) 7.2 EU Oligonucleotide Synthesis Market Size by Application (2015-2019) Chapter 8 Japan Oligonucleotide Synthesis Development Status and Outlook 8.1 Japan Oligonucleotide Synthesis Market Size (2015-2019) 8.2 Japan Oligonucleotide Synthesis Market Size by Application (2015-2019) Chapter 9 China Oligonucleotide Synthesis Development Status and Outlook 9.1 China Oligonucleotide Synthesis Market Size and Forecast (2015-2019) 9.2 China Oligonucleotide Synthesis Market Size by Application (2015-2019) Chapter 10 India Oligonucleotide Synthesis Development Status and Outlook 10.1 India Oligonucleotide Synthesis Market Size and Forecast (2015-2019) 10.2 India Oligonucleotide Synthesis Market Size by Application (2015-2019) Chapter 11 Southeast Asia Oligonucleotide Synthesis Development Status and Outlook 11.1 Southeast Asia Oligonucleotide Synthesis Market Size and Forecast (2015-2019) 11.2 Southeast Asia Oligonucleotide Synthesis Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global Oligonucleotide Synthesis Market Size (Million USD) by Regions (2020-2027) 12.1. North America Oligonucleotide Synthesis Revenue and Growth Rate (2020-2027) 12.1.2 EU Oligonucleotide Synthesis Revenue and Growth Rate (2020-2027) 12.1.3 China Oligonucleotide Synthesis Revenue and Growth Rate (2020-2027) 12.1.4 Japan Oligonucleotide Synthesis Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia Oligonucleotide Synthesis Revenue and Growth Rate (2020-2027) 12.1.6 India Oligonucleotide Synthesis Revenue and Growth Rate (2020-2027) 12.2 Global Oligonucleotide Synthesis Market Size by Application (2020-2027) Chapter 13 Oligonucleotide Synthesis Market Dynamics 13.1 Oligonucleotide Synthesis Market Opportunities 13.2 Oligonucleotide Synthesis Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Oligonucleotide Synthesis Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Oligonucleotide Synthesis Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
6775

3555

OUR CLIENT